DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q3 2021 13F-HR Holdings
Net value change ($000)
-505,747
(-9.0%)
New positions
19
Sold out positions
37
Turnover %
40.9%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q2 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NUVL | 436,140 | NEW |
| WGS | 105,110 | NEW |
| IVERIC bio, Inc. | 42,595 | 117.0% |
| NBIX | 39,012 | 55.3% |
| CYTK | 30,422 | 124.2% |
| GKOS | 29,817 | NEW |
| VINC | 22,303 | NEW |
| DAWN | 21,948 | 117.7% |
| AERIE PHARMACEUTICALS INC | 20,715 | 156.7% |
| Montes Archimedes Acquisition Corp | 18,700 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Singular Genomics Systems, Inc. | -148,435 | -59.3% |
| CareMax, Inc. | -54,363 | -25.1% |
| ZBH | -54,357 | -100.0% |
| CONSTELLATION PHARMACEUTICALS INC | -54,128 | -100.0% |
| QUIDEL CORP /DE/ | -52,429 | -100.0% |
| Acutus Medical, Inc. | -50,312 | -68.2% |
| GLPG | -45,261 | -100.0% |
| REATA PHARMACEUTICALS INC | -42,459 | -100.0% |
| ACH | -42,182 | -100.0% |
| BCRX | -41,449 | -92.5% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
9,412
(0.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|